Catalyst Wire Dossier Catalyst Wire Dossier

PTC124/Nonsense mutation Duchenne muscular dystrophy therapy

drisapersen? (note: actual generic used for PTC Therapeutics with nonsense mutations is ataluren? If unspecified, flag as null) · PTC Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PTC124/Nonsense mutation Duchenne muscular dystrophy therapy, covering 2022-04-05 to 2022-04-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) [Phase 2]

See pricing